Detalhe da pesquisa
1.
Pivotal Role of TNF-α in the Development and Progression of Nonalcoholic Fatty Liver Disease in a Murine Model.
Horm Metab Res
; 50(1): 80-87, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28922680
2.
Definitive diagnosis of mandibular hypoplasia, deafness, progeroid features and lipodystrophy (MDPL) syndrome caused by a recurrent de novo mutation in the POLD1 gene.
Endocr J
; 65(2): 227-238, 2018 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-29199204
3.
Age-related changes in the diurnal variation of ketogenesis in patients with type 2 diabetes and relevance to hypoglycemic medications.
Endocr J
; 62(3): 235-41, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25392021
4.
Insulin Resistance Is Better Estimated by Using Fasting Glucose, Lipid Profile, and Body Fat Percent Than by HOMA-IR in Japanese Patients with Type 2 Diabetes and Impaired Glucose Tolerance: An Exploratory Study.
Metab Syndr Relat Disord
; 22(3): 199-206, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38190491
5.
Modulation by adiponectin of circadian clock rhythmicity in model mice for metabolic syndrome.
Endocr J
; 60(4): 483-92, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23292171
6.
Prevalence and clinical characteristics of unremembered nocturnal eating in diabetic subjects: Kurume sleep trouble in obesity and metabolic disorders (KUSTOMED) study.
Endocr J
; 60(9): 1059-63, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23774071
7.
Disrupted regulation of ghrelin production under antihypertensive treatment in spontaneously hypertensive rats.
Circ J
; 76(6): 1423-9, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22447011
8.
Long-term efficacy of sitagliptin for the treatment of type 2 diabetic patients in Japan.
Endocr J
; 59(3): 197-204, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22156327
9.
Effects of exercise therapy alone and in combination with a calcium channel blocker or an angiotensin receptor blocker in hypertensive patients.
Clin Exp Hypertens
; 34(7): 523-9, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22559159
10.
Beneficial effects of SGLT2 inhibitor on metabolic inflexibility and visceral fat amount in animal model of obese type 2 diabetes.
Heliyon
; 8(10): e11012, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36281369
11.
Two-year administration of sodium-glucose co-transporter 2 inhibitor brought about marked reduction of body fat independent of skeletal muscle amount or glycemic improvement in Japanese patients with type 2 diabetes.
Diabetol Int
; 13(1): 117-123, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35059247
12.
[Elderly diabetic patients and exercise].
Nihon Rinsho
; 74 Suppl 2: 566-70, 2016 Apr.
Artigo
em Japonês
| MEDLINE | ID: mdl-27266154
13.
Distinct Relevance of Nightly Sleep Duration to Metabolic, Anthropometric, and Lifestyle Factors in Patients with Type 2 Diabetes.
Intern Med
; 60(5): 681-688, 2021 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33087663
14.
Clinical characteristics of thyroid abnormalities induced by sunitinib treatment in Japanese patients with renal cell carcinoma.
Endocr J
; 57(10): 873-80, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20733268
15.
Pathophysiology of gestational diabetes mellitus in lean Japanese pregnant women in relation to insulin secretion or insulin resistance.
Diabetol Int
; 11(3): 269-273, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32802708
16.
Improvement of skeletal muscle insulin sensitivity by 1 week of SGLT2 inhibitor use.
Endocr Connect
; 9(7): 599-606, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32580152
17.
Voluntary exercise is motivated by ghrelin, possibly related to the central reward circuit.
J Endocrinol
; 244(1): 123-132, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31629323
18.
Human Leukocyte Antigen (HLA) Subtype-Dependent Development of Myasthenia Gravis, Type-1 Diabetes Mellitus, and Hashimoto Disease: A Case Report of Autoimmune Polyendocrine Syndrome Type 3.
Am J Case Rep
; 20: 1709-1714, 2019 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31745069
19.
A High-Fat/High-Sucrose Diet Induces WNT4 Expression in Mouse Pancreatic ß-cells.
Kurume Med J
; 65(2): 55-62, 2019 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30853690
20.
Bromocriptine as a Potential Glucose-lowering Agent for the Treatment of Prolactinoma with Type 2 Diabetes.
Intern Med
; 58(21): 3125-3128, 2019 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31243214